apomorphine has been researched along with Allodynia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galeotti, N; Ghelardini, C; Peroni, D; Quattrone, A; Sanna, MD | 1 |
| Constandil, L; Eschalier, A; Hernandez, A; Laurido, C; Pelissier, T | 1 |
| Giridharagopalan, S; Hamamoto, DT; Simone, DA | 1 |
| Antkiewicz-Michaluk, L; Michaluk, J; Vetulani, J | 1 |
4 other study(ies) available for apomorphine and Allodynia
| Article | Year |
|---|---|
Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy.
Topics: Analgesics, Non-Narcotic; Animals; Anti-HIV Agents; Apomorphine; Calcium Channel Blockers; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; ELAV Proteins; ELAV-Like Protein 4; Exploratory Behavior; Gene Expression Regulation; Hyperalgesia; Male; Mice; Motor Activity; Neuroblastoma; Pain; Pain Threshold; Peripheral Nervous System Diseases; Ryanodine Receptor Calcium Release Channel; Spinal Cord; Zalcitabine | 2015 |
Biphasic effect of apomorphine on rat nociception and effect of dopamine D2 receptor antagonists.
Topics: Analgesics; Animals; Apomorphine; Domperidone; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Formaldehyde; Hyperalgesia; Male; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Time Factors | 2006 |
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
Topics: Animals; Apomorphine; Benzoxazines; Cannabinoid Receptor Agonists; Catalepsy; Cyclohexanes; Cyclohexanols; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Morpholines; Naphthalenes; Phenols; Receptors, Cannabinoid; Sarcoma, Experimental | 2007 |
Modification of effects of chronic electroconvulsive shock by voltage-dependent Ca2+ channel blockade with nifedipine.
Topics: Animals; Apomorphine; Behavior, Animal; Calcium Channel Blockers; Calcium Channels; Cerebral Cortex; Electroshock; Hippocampus; Hyperalgesia; Male; Membranes; Motor Activity; Nifedipine; Nitrendipine; Rats; Rats, Wistar; Seizures; Up-Regulation; Weight Gain | 1994 |